Article in Medical image analysis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 3 institutions in 1 country.
Samuel GerberKitware Inc., NC, USA.
Marc NiethammerUniversity of North Carolina, Chapel Hill, NC, USA.
Ebrahim EbrahimKitware Inc., NC, USA. Electronic address: ebrahim.ebrahim@kitware.com.
Joseph PivenUniversity of North Carolina, Chapel Hill, NC, USA.
Stephen R DagerUniversity of Washington, Seattle, WA, USA.
Martin StynerUniversity of North Carolina, Chapel Hill, NC, USA.
Stephen AylwardKitware Inc., NC, USA.
Andinet EnquobahrieKitware Inc., NC, USA.
University of North Carolina at Chapel Hill · USKitware (United States) · USUniversity of Washington · US
Funding
Cellular and molecular mechanisms governing cortical surface area overgrowth in iPSC-derived neural cells from longitudinally characterized individuals with autismR01HD055741 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph Piven · 2007 to 2026
$52.6M
Preclinical CoreU54HD079124 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MOY, SHERYL S · 2013 to 2019
$8.0M
Shape Analysis Toolbox: From medical images to quantitative insights of anatomyR01EB021391 · NIBIB · KITWARE, INC. · PI PANIAGUA, BEATRIZ · 2016 to 2024
$3.5M
Stationary Digital Tomosynthesis for Transbronchial Biopsy GuidanceR01EB028283 · NIBIB · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LEE, YUEH Z · 2019 to 2023
$2.9M
Slicer+PLUS: Collaborative, open-source software for ultrasound analysisR01EB021396 · NIBIB · KITWARE, INC. · PI AYLWARD, STEPHEN R, FICHTINGER, GABOR · 2016 to 2019
$2.5M
Enhanced Software Tools for Detecting Anatomical Differences in Image Data SetsR42MH118845 · NIMH · KITWARE, INC. · PI ANCES, BEAU M, ENQUOBAHRIE, ANDINET ASMAMAW · 2020 to 2021
$1.5M
Multimodality Image-Based Assessment System for Traumatic Brain InjuryR44NS081792 · NINDS · KITWARE, INC. · PI AYLWARD, STEPHEN R, NIETHAMMER, MARC · 2015 to 2016
$1.3M
Quantitative Ultrasound Analysis of Vascular Morphology for Cancer AssessmentR44CA165621 · NCI · KITWARE, INC. · PI AYLWARD, STEPHEN R, DAYTON, PAUL A · 2015 to 2016
$1.3M
Automated Assessment of Leptomeningeal Collaterals on CT AngiogramsR42NS086295 · NINDS · KITWARE, INC. · PI AYLWARD, STEPHEN R, LEE, YUEH Z · 2018 to 2019
Brain pathologies often manifest as partial or complete loss of tissue. The goal of many neuroimaging studies is to capture the location and amount of tissue changes with respect to a clinical variable of interest, such as disease progression. Morphometric analysis approaches capture local differences in the distribution of tissue or other quantities of interest in relation to a clinical variable. We propose to augment morphometric analysis with an additional feature extraction step based on unbalanced optimal transport. The optimal transport feature extraction step increases statistical power for pathologies that cause spatially dispersed tissue loss, minimizes sensitivity to shifts due to spatial misalignment or differences in brain topology, and separates changes due to volume differences from changes due to tissue location. We demonstrate the proposed optimal transport feature extraction step in the context of a volumetric morphometric analysis of the OASIS-1 study for Alzheimer's disease. The results demonstrate that the proposed approach can identify tissue changes and differences that are not otherwise measurable.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Optimal transport features for morphometric population analysis. · full record | OpenQuestion